Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
Same as current

Summary

Conditions
  • Efficacy, Self
  • Endovascular Treatment
  • Lower Extremity Problem
  • Safety Issues
  • Thromboembolic Disease
Type
Observational
Design
Observational Model: Case-OnlyTime Perspective: Prospective

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Description

According to the Trans-Atlantic Inter-Society Consensus (TASC) II guidelines, acute arterial occlusion which in stage IIb was recommended for thrombectomy. However, with the development of new tools, including drug coated balloon, paclitaxel eluting stent, interwoven stents, debulking tools, stage I...

According to the Trans-Atlantic Inter-Society Consensus (TASC) II guidelines, acute arterial occlusion which in stage IIb was recommended for thrombectomy. However, with the development of new tools, including drug coated balloon, paclitaxel eluting stent, interwoven stents, debulking tools, stage IIb patients and some subacute thromboembolic lesions were also effective in some retrospective studies. Despite The shift of Endovascular-first strategy has been documented in recent literature. There still lack evidence to support either approach have a significant advantage over the thrombectomy. And stage IIb lesions and subacute lesions are often excluded in prospective clinical trials. Therefore, a well-designed real-world study that track the safety and clinical relevant outcomes, are required to determine the optimal therapies for patients with acute or subacute thromboembolic occlusions of lower extremity.

Tracking Information

NCT #
NCT04861506
Collaborators
  • RenJi Hospital
  • First Affiliated Hospital of Zhejiang University
  • Xuanwu Hospital, Beijing
  • Qingdao haici hospital
  • Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology
  • Second Affiliated Hospital of Suzhou University
  • Chengdu University of Traditional Chinese Medicine
  • Shanghai Zhongshan Hospital
Investigators
Principal Investigator: Meng Ye RenJi Hospital Principal Investigator: Ziheng Wu First Affiliated Hospital of Zhejiang University Principal Investigator: Lianrui Guo Xuanwu Hospital, Beijing Principal Investigator: Qiang Li Qingdao haici hospital Principal Investigator: Zibo Feng Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology Principal Investigator: Hongfei Sang Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology Principal Investigator: Chunshui He Chengdu University of Traditional Chinese Medicine Principal Investigator: Zhenyu Shi Shanghai Zhongshan Hospital Principal Investigator: Xupin Xie First People's Hospital of Hangzhou Principal Investigator: Jianyun Long First People's Hospital of Hangzhou